Faruqi Faruqi LLP Reminds Regencell Bioscience RGC Investors of Upcoming Securities Class Action Deadline Softtech Engineers Stock Eyes Breakout Above 470 Q4 Results in Focus UBS Highlights TotalEnergies TTE as a Preferred European Energy Stock Petraeus Suggests Iran May Concede on Strait of Hormuz in Potential Peace Deal EU and Mexico Renew Trade Pact as Geopolitical Tensions Reshape Global Alliances DeepSeek Chinese AI Model Earns Silicon Valley Praise Despite Chip Hurdles SUI Q1 2026 Earnings Misses EPS Estimates with Surprise Loss ASAN Q1 2026 Earnings EPS Beat Surprises Market Stock Surges 4 AU Q1 2026 Earnings EPS Beats Estimates by 806 Stock Rises 756 CMG Q1 2026 Earnings EPS Slightly Misses Estimates Stock Declines 176 PhenixFIN Corporation PFX Q1 2026 Earnings Strong EPS Surprise of 254 Amid Stable Market Conditions CVEO Q1 2026 Earnings Solid EPS Beat Provides Modest Glimmer Amid Seasonal Headwinds Angel Oak Financial Strategies Income Term Trust FINS Edges Lower as YieldSeeking Investors Weigh Positions Atlanticus Holdings Senior Notes ATLCL Edge Lower as Yield Dynamics Weigh on FixedIncome Sentiment Chemed Corp CHE Edges Higher Amid Steady Trading Key Levels to Watch Blue Acquisition Corp BACC Holds Steady Near Resistance as Trading Activity Remains Quiet CytomX Therapeutics CTMX Faces Selling Pressure as Stock Declines 26 Towards Key Support JW Therapeutics CEO China Pharma Sector Unaffected by Beijings Tech Deal Scrutiny FB Financial Q1 2026 Earnings Slight EPS Miss Meets Modest Stock Gains Nelnet Inc NNI Gains 12 as Stock Holds Above Key Support Level BKTI Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiencies GXAI Q1 2026 Earnings EPS Misses Estimates Stock Declines Guidewire Q1 2026 Earnings EPS Surges Past Estimates by 484 as Operating Performance Strengthens Credit Acceptance Corporation CACC Q1 2026 Earnings EPS Falls Just Short of Estimates Stock Declines STXS Q1 2026 Earnings LargerThanExpected Loss as Company Continues Strategic Transition enVVeno Medical Q3 2025 Earnings Narrower Loss Beats Expectations as Clinical Programs Advance AWK Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain